Not everyone wants — or needs — the highest GLP-1 dose. 'Microdosing' refers to using lower doses of medications like semaglutide or tirzepatide for gentler appetite and metabolic support, rather than maximum weight loss as fast as possible.
Who considers it
- Women who don't meet the higher-BMI threshold but want metabolic and appetite support.
- People sensitive to side effects who tolerate lower doses better.
- Those focused on maintaining a result, or on energy, cravings, and insulin rather than rapid loss.
Potential benefits
At lower doses, many people report reduced cravings and 'food noise,' steadier energy, and better appetite control with milder side effects than full doses can cause. For some, it's a sustainable long-term tool rather than a short, intense course.
Important caveats
Microdosing is still a prescription medical decision — dosing, eligibility, and monitoring are determined by a licensed provider. 'Lower dose' is not the same as 'no oversight,' and results vary. It's best thought of as one option a provider may consider, not a do-it-yourself protocol.